Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 12, 2007, Pages 5558-5566

  Zenkel, Matthias ^a   Kruse, Friedrich E ^a   Naumann, Gottfried O H ^a   Schlötzer Schrehardt, Ursula ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE T1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 60; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN MLH1; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME 2A; UBIQUITIN CONJUGATING ENZYME 2B; UNCLASSIFIED DRUG; EYE PROTEIN; HEAT SHOCK PROTEIN; TRANSCRIPTION FACTOR;

AGED; ANTERIOR EYE SEGMENT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DNA HYBRIDIZATION; DOWN REGULATION; EYE; FEMALE; GENE; GENE EXPRESSION; GLAUCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOEXFOLIATION; REAL TIME POLYMERASE CHAIN REACTION; STRESS; WESTERN BLOTTING; DNA MICROARRAY; EXFOLIATION SYNDROME; GENE EXPRESSION REGULATION; GENETICS; IN SITU HYBRIDIZATION; METABOLISM; OPEN ANGLE GLAUCOMA; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ANTERIOR EYE SEGMENT; BLOTTING, WESTERN; EXFOLIATION SYNDROME; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GLAUCOMA, OPEN-ANGLE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 38549141699     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0750     Document Type: Article

References (48)

1. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.
2. Naumann GOH, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Ophthalmology. 1998;105:951-968.
3. Zenkel M, Pöschl E, von der Mark K, et al. Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 2005;46:3742-3752.
4. Schlötzer-Schrehardt U, Naumann GOH. Perspective: ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006; 141:921-937.
5. Ovodenko B, Rostagno A, Neubert TA, et al. Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci. 2007;48:1447-1457.
6. Koliakos GG, Konstas AGP, Schlötzer-Schrehardt U, et al. 8-isoprostaglandin F2A and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol. 2003;87:353-356.
7. Gartaganis SP, Georgakopoulos CD, Patsoukis NE, Gotsis SS, Gartaganis VS, Georgiou CD. Glutathione and lipid peroxide changes in pseudoexfoliation syndrome. Curr Eye Res. 2005;30:647-651.
8. Gartaganis SP, Patsoukis NE, Nikolopoulos DK, Georgiou CD. Evidence for oxidative stress in lens epithelial cells in pseudoexfoliation syndrome. Eye. Published online September 22, 2006.
9. Koliakos GG, Konstas AGP, Schlötzer-Schrehardt U, et al. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol. 2004;88:523-527.
10. Bleich S, Roedl J, von Ahsen N, et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162-164.
11. Yilmaz A, Adigüzel U, Tamer L, et al. Serum oxidant/antioxidant balance in exfoliation syndrome. Clin Exp Ophthalmol. 2005;33: 63-66.
12. Yagci R, Gürel A, Ersöz I, et al. Oxidative stress and protein oxidation in pseudoexfoliation syndrome. Curr Eye Res. 2006;31: 1029-1032.
13. Zenkel M, Kruse FE, Jünemann AG, Naumann GOH, Schlötzer- Schrehardt U. Deficiency of the extracellular chaperone clusterin in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci. 2006;47:1982-1990.
14. Rozen S, Skaletzky HJ. Primer 3 Code; 1998; available at http:// www-genome.wi.mit.edu/genome_software/other/primer3.html.
15. Schlötzer-Schrehardt U, Zenkel M, Nüsing RM. Expression and Localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci. 2002;43:1475-1486.
16. Zien A, Aigner T, Zimmer R, Lengauer T. Centralization: a new method for the normalization of gene expression data. Bioinformatics. 2001;17:323-331.
17. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68:320-344.
18. Macmillan-Crow LA, Cruthirds DL. Invited review: manganese superoxide dismutase in disease. Free Radic Res. 2001;34:325-336.
19. Yenari MA. Heat shock proteins and neuroprotection. Adv Exp Med Biol. 2002;513:281-299.
20. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006;97:1634-1658.
21. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001;35:297-306.
22. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88.
23. Ahmad H, Singh SV, Medh RD, Ansari GA, Kurosky A, Awasthi YC. Differential expression of alpha, mu and pi classes of isoenzymes of glutathione-S-transferase in bovine lens, cornea, and retina. Arch Biochem Biophys. 1988;266:416-426.
24. Ahmad H, Singh SV, Srivastava SK, Awasthi YC. Glutathione-S-transferase of bovine iris and ciliary body: characterization of isoenzymes. Curr Eye Res. 1989;8:175-184.
25. Srivastava SK, Singhal SS, Bajpai KK, Chaubey M, Ansari NH, Awasthi YC. A group of novel glutathione S-transferase isoenzymes showing high activity towards 4-hydroxy-2-nonenal are present in bovine ocular tissues. Exp Eye Res. 1994;59:151-159.
26. Maeda A, Crabb JW, Palczewski K. Microsomal glutathione-S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging. Biochemistry. 2005; 44:480-489.
27. Mosialou E, Piemonte F, Andersson C, Vos RM, van Bladeren PJ, Morgenstern R. Microsomal glutathione transferase: lipid-derived substrates and lipid dependence. Arch Biochem Biophys. 1995; 320:210-216.
28. Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J. 1997;11:526-534.
29. Ciechanover A, Orian A, Schwartz AL. Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays. 2000; 22:442-451.
30. Nandi D, Tahiliani P, Kumar A, Chandu D. The ubiquitin-proteasome system. J Biosci. 2006;31:137-155.
31. Koken MH, Reynolds P, Jaspers-Dekker I, et al. Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6. Proc Natl Acad Sci USA. 1991;88:8865-8869.
32. Roest HP, Baarends WM, de Wit J, et al. The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice. Mol Cell Biol. 2004;24:5485-5495.
33. Tomasino A, Klimaschewski L. Tissue distribution of the "N-end rule" ubiquitin-conjugating enzyme, HR6, in the rat. Histochem Cell Biol. 2005;123:483-489.
34. Sasaki H, Moriyama S, Nakashima Y, Yukiue H, Fukai I, Fujii Y. Decreased Hrad6B expression in lung cancer. Acta Oncol. 2004; 43:585-589.
35. Shang F, Gong X, Palmer HJ, Nowell TR Jr, Taylor A. Age-related decline in ubiquitin conjugation in response to oxidative stress in the lens. Exp Eye Res. 1997;64:21-30.
36. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11:381-389.
37. Yam GH, Gaplovska-Kysela K, Zuber C, Roth J. Aggregated myocilin induces Russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma. Am J Pathol. 2007;170:100-109.
38. Teixeira PF, Cerca F, Santos SD, Saraiva MJ. Endoplasmic reticulum stress associated with extracellular aggregates: evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem. 2006;281:21998-22003.
39. Paschen W, Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium. 2005;38:409-415.
40. Paschen W, Mengesdorf T, Althausen S, Hotop S. Peroxidative stress selectively down-regulates the neuronal stress response activated under conditions of endoplasmic reticulum dysfunction. J Neurochem. 2001;76:1916-1924.
41. Iyer RR, Pluciennik A, Burdett V, Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev. 2006;106:302-323.
42. Esteller M, Catasus L, Matias-Guiu X, et al. hMLH1 Promotor Hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol. 1999;155:1767-1772.
43. Boerrigter ME, Wei JY, Vijg J. DNA repair and Alzheimer's disease. J Gerontol. 1992;47:B177-B184.
44. Schlötzer-Schrehardt U, Zenkel M, Küchle M, Sakai LY, Naumann GOH. Role of transforming growth factor-β and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73:765-780.
45. Tadlock L, Yamagiwa Y, Hawker J, Marienfeld C, Patel T. Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest. Am J Physiol. 2003;285: C277-C285.
46. Kayanoki Y, Fujii J, Suzuki K, Kawata S, Matsuzawa Y, Taniguchi N. Suppression of antioxidative enzyme expression by transforming growth factor-β1 in rat hepatocytes. J Biol Chem. 1994;269: 15488-15492.
47. Caballero M, Liton PB, Epstein DL, Gonzalez P. Proteasome inhibition by chronic oxidative stress in human trabecular meshwork cells. Biochem Biophys Res Commun. 2003;308:346-352.
48. Iglesias de la Cruz MC, Ruiz-Torres P, Alcami J, et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int. 2001;59:87-95.